DR info

Clinical trials : 111 / Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61

Lennox-Gastaut syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
144	Lennox-Gastaut syndrome
140	Dorabe syndrome
6	Parkinson disease
13	Multiple sclerosis/Neuromyelitis optica
156	Rett syndrome
97	Ulcerative colitis
2	Amyotrophic lateral sclerosis
193	Prader-Willi syndrome
8	Huntington disease
206	Fragile X syndrome
145	West syndrome
298	Hereditary pancreatitis
18	Spinocerebellar degeneration
17	Multiple system atrophy
3	Spinal muscular atrophy
5	Progressive supranuclear palsy
70	Spinal stenosis
272	Fibrodysplasia ossificans progressiva
96	Crohn disease
36	Epidermolysis bullosa
231	Alpha-1-antitrypsin deficiency
152	PCDH19 related syndrome
46	Malignant rheumatoid arthritis
155	Acquired aphasia with convulsive disorder
201	Angelman syndrome
158	Tuberous sclerosis
205	Fragile X syndrome related disease
84	Sarcoidosis
34	Neurofibromatosis
22	Moyamoya disease
98	Eosinophilic gastrointestinal disease
21	Mitochondrial disease
296	Biliary atresia
75	Cushing disease
203	22q11.2 deletion syndrome
226	Interstitial cystitis with Hunners ulcer
149	Hemiconvulsion hemiplegia epilepsy syndrome
86	Pulmonary arterial hypertension
114	Non-dystrophic myotonia syndrome
58	Hypertrophic cardiomyopathy
168	Ehlers-Danlos syndrome
1	Spinal and bulbar muscular atrophy
51	Scleroderma
10	Charcot-Marie-Tooth disease
90	Retinitis pigmentosa
127	Frontotemporal lobar degeneration
38	Stevens-Johnson syndrome
167	Marfan syndrome
81	Congenital adrenal hyperplasia
256	Muscle glycogenosis
28	Systemic amyloidosis
202	Smith-Magenis syndrome